Bimatoprost finishing up Phase IIb trial!

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • Pelopeleon
    replied
    So, Do you think we will be able to buy bimatoprost x% from Asia markets in 2015?

    Leave a comment:


  • beetee
    replied
    Originally posted by ChemicalBrother
    excellent news indeed - thanks for the research beetee

    Care to layout the next steps and timeframe for where we go from here ?
    No problem at all, glad to see some people were interested. I was following the process of the takeover attempt a little too closely since it started last march and while there were definitely times when things did not look good, one of the best possible outcomes has occurred and I am very happy about that.

    The current clinical trial is set to be completed January 2015, as indicated on their listing on clinicaltrials.gov. Allergan typically releases the results of their clinical trials within several months of their completion, and hopefully that will continue to be the case under their new owners. When allergan announced the results of the last clinical trial for this product in May 2013 they actually described the current ongoing trial as the first of two that they had planned. It's good that they are (or were) committed to fully investigating this drug's potential, and hopefully we'll hear something one way or the other about the current trial results early in the new year. As far as the second trial, i imagine it could be abandoned if the results of the current one are very good or very bad, or it may go ahead regardless.

    I believe this is all there is to know at this point . While the future is still uncertain, this is a legitimate possibility and a very well established and professional company, so there's definitely reason to keep following this, if not to feel slightly hopeful.

    Leave a comment:


  • It's2014ComeOnAlready
    replied
    Btw - does anybody know if there's any evidence out there that shows bimatoprost could be more effective with something like dermaroliing?

    Leave a comment:


  • It's2014ComeOnAlready
    replied
    66 billion is a LOT of money, let's hope that figure means they are banking on some impressive results from bimatoprost.

    Leave a comment:


  • ChemicalBrother
    replied
    excellent news indeed - thanks for the research beetee

    Care to layout the next steps and timeframe for where we go from here ?

    Leave a comment:


  • rdawg
    replied
    That's very good news, the results of a higher solution will be very interesting!

    first growth stimulant to get close to release since minoxidil!!

    Leave a comment:


  • Kudu
    replied
    Great! Thanks for posting

    Leave a comment:


  • beetee
    replied
    Excellent news! Actavis has taken over allergan and valeant has said they will not try to compete. At the least, this should mean that we'll eventually know what the results of the clinical trials were.

    This is pure speculation, but actavis spent a ton of money for allergan, 66 billion. That's 13 billion more than valeant's highest offer. Actsvis had stated that they will not cut any research and development and there's probably not much money to be gained by synergies between the two company's product lines. So they're hoping to make money the good old fashioned way: by introducing new products that will generate big sales. Granted Botox has many under exploited applications, but it's fair to assume that actavis believes allergan has some big moneymakers in the pipeline. Here's hoping it's bimatiprost for hair!

    Leave a comment:


  • beetee
    replied
    Originally posted by rambo007
    This is old news and in it they framed the results in a certain way. What Allergan found is that when they used the original formulation that has the same concentration that is used for eyelash growth that it regrew some hair but not enough for them to go forward with further investigations. So they did what they had always planned on doing: increasing the concentration and changing the formulation to try to get better absorption through the thick skin on the scalp to get the active ingredients to the follicles. This is basically what they planned on doing all along.

    That being said, they may still not get sufficient results. But the results of that trial that is being written about is not proof or even good evidence that it won't work. The results of the upcoming trial will be much more informative.

    Leave a comment:


  • cocacola
    replied
    Originally posted by rambo007
    Feels more like belgravia center is worried about their consultations and inhouse minox formulas sales...

    Leave a comment:


  • lilpauly
    replied
    Latanoprost 22% Density Increase.

    Leave a comment:


  • locke999
    replied
    Phase 3 is the most expensive and where companies fail the most.

    I wouldn't get my hopes up until any of these companies are even in the middle of phase 3.

    Leave a comment:


  • rambo007
    replied
    Not good news

    Information and advice on hair loss, the treatments that work, and the ones that don't Plus photos, videos and comments from hair loss treatment users

    Leave a comment:


  • lilpauly
    replied
    Any1 try Lanaport

    Leave a comment:


  • lilpauly
    replied
    i think they are goingto have a anoter clincal study using a stronget strength!

    Leave a comment:

Working...